Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
Formulators are moving toward botanicals like ashwagandha, bacopa, saffron, and PEA that target the stress, cortisol, and nervous-system pathways behind restless nights.
Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.